MONTIYAN-L Tablets

MONTIYAN-L Tablets – Dual Action Antiallergic Therapy

MONTIYAN-L is a fixed-dose combination of **Levocetirizine Hydrochloride and Montelukast**, formulated to provide comprehensive control of allergic symptoms affecting the upper and lower respiratory tract.

Scientific Rationale

Allergic conditions involve histamine release and leukotriene-mediated inflammation. The combination of an antihistamine with a leukotriene receptor antagonist offers broader symptom control compared to monotherapy.

Mechanism of Action

Levocetirizine selectively blocks H1 receptors, reducing sneezing, itching and rhinorrhoea.
Montelukast inhibits leukotriene receptors, decreasing airway inflammation, bronchoconstriction and allergy-related cough.

Indications and Benefits

Seasonal and perennial allergic rhinitis.
Allergy-associated cough and wheezing.
Sneezing, nasal congestion and watery eyes.
Adjunct therapy in allergic airway disorders.

Dosage

To be taken as directed by the physician, preferably in the evening.

Safety Information

Generally well tolerated when used as prescribed.
Use under medical supervision in patients with hepatic impairment.
Not intended to replace medical advice.

MONTIYAN-L provides effective, well-balanced antiallergic control with sustained symptom relief.